Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
Biosimilars are as safe and efficient for use as cancer medication as the original - News - Utrecht University
SciELO - Saúde Pública - Hubs to spread technology and save lives Hubs to spread technology and save lives
Peperduur medicijn voor een schijntje nagemaakt | De Volkskrant
Dure medicijnen mogelijk betaalbaar door Utrechtse uitvinding | De Utrechtse Internet Courant
PDF) Biosimilar therapeutics—What do we need to consider?
PDF) Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
Huub Schellekens | Writers Unlimited
Pharmaceutical Technology Europe - August 2010 - What is Hindering the Uptake of Biosimilars
Immunogenicity and glycosylation: The key issues for biosimilars - ppt video online download
PDF) Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates
PDF) Challenges in standardizing safety assessments of biopharmaceuticals, the case of EPREX Associated Pure Red Cell Aplasia | Toine Pieters - Academia.edu
Huub Schellekens - HR Business Partner - Feenstra | LinkedIn
Huub Schellekens - HR Business Partner - Feenstra | LinkedIn
Evaluation of the suitability of a Sprague Dawley rat model to assess intravenous iron preparations
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
Huub Schellekens – Studium Generale Universiteit Utrecht
BIOLOGICALS UIT DE BIO-NESPRESSO?
Impact of Biosimilar Insulins on Clinical Practice
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
Huub Schellekens | European Association of Hospital Pharmacists
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
Catalogus Professorum - Prof Detail
Huub Schellekens – Studium Generale Universiteit Utrecht
